Doorgaan naar hoofdnavigatie Doorgaan naar zoeken Ga verder naar hoofdinhoud

The PRECIS-2 tool has good interrater reliability and modest discriminant validity

  • Kirsty Loudon
  • , Merrick Zwarenstein
  • , Frank Sullivan
  • , Peter Donnan
  • , Ildikó Gágyor
  • , Hans Hobbelen
  • , Fernando Althabe
  • , Jerry A Krishnan
  • , Shaun Treweek
  • NMAHP Research Unit, Stirling University
  • Centre for Studies in Family Medicine, Schulich School of Medicine & Dentistry, Western University, Western Centre for Public Health and Family Medicine
  • Division of Population Health Sciences, University of Dundee
  • Department of General practice, University Medical Center Göttingen
  • Departamento de Investigación en Salud de la Madre y el Niñom, Instituto de Efectividad Clínica y Sanitaria (IECS)
  • Population Health Sciences, University of Illinois
  • Health Services Research Unit, University of Aberdeen

Onderzoeksoutput: Article › Academic › peer review

Samenvatting

OBJECTIVE: PRECIS - 2 is a tool that could improve design insight for trialists. Our aim was to validate the PRECIS - 2 tool, unlike its predecessor, testing the discriminant validity and inter-rater reliability.

STUDY DESIGN AND SETTING: Over 80 international trialists, methodologists, clinicians and policymakers created PRECIS - 2 helping to ensure face and content validity. The inter-rater reliability of PREC IS - 2 was measured using 19 experienced trialists who used PRECIS - 2 to score a diverse sample of 15 RCT protocols. Discriminant validity was tested with two raters to independently determine if the trial protocols were more pragmatic or more explanatory, with scores from the 19 raters for the 15 trials as predictors of pragmatism.

RESULTS: Inter-rater reliability was generally good, with seven out of nine domains having an ICC over 0.65. Flexibility (Adherence) and Recruitment had wide confidence intervals but raters found these difficult to rate and wanted more information. Each of the nine PRECIS - 2 domains could be used to differentiate between trials taking more pragmatic or more explanatory approaches with better than chance discrimination for all domains.

CONCLUSION: We have assessed the validity and reliability of PRECIS - 2. An elaboration paper and website provide guidance to help future users of the tool which is continuing to be tested by trial teams, systematic reviewers and funders.

Originele taal-2English
Pagina's (van-tot)113-121
TijdschriftJournal of Clinical Epidemiology
Volume88
DOI's
StatusPublished - 8 jun. 2017

Duurzame ontwikkelingsdoelstellingen van de VN

Deze output draagt bij aan de volgende duurzame ontwikkelingsdoelstelling(en)

  1. SDG 03 – Goede gezondheid en welzijn
    SDG 03 – Goede gezondheid en welzijn

Keywords

  • gezondheidssector
  • onderzoek
  • methodiek

Research Focus Areas Hanze University of Applied Sciences

  • Healthy Ageing

Research Focus Areas Research Centre or Centre of Expertise

  • Kwetsbaarheid en passende zorg

Publinova thema's

  • Overig
  • Gezondheid

Vingerafdruk

Duik in de onderzoeksthema's van 'The PRECIS-2 tool has good interrater reliability and modest discriminant validity'. Samen vormen ze een unieke vingerafdruk.

Citeer dit